Adriano Chio

Rome, IT

Expertise in

conditions

Rome, IT

OverviewLocationsClinical Research

Overview

Adriano Chio practices in Rome, Italy. Mr. Chio is highly rated in 12 conditions, according to our data. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Frontotemporal Dementia, Dementia, and Gastrostomy.

His clinical research consists of co-authoring 429 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender

Male

Locations

Rome, Italy

Other Locations

Turin, Italy

Piemonte, Italy

Levi, Italy

Pavia, Italy

San Giovanni Battista, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1/2 Multiple-Ascending-Dose Study With a Long-Term Open-Label Extension to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Effect on Disease Progression of BIIB105 Administered Intrathecally to Adults With Amyotrophic Lateral Sclerosis With or Without Poly-CAG Expansion in the ATXN2 Gene

Enrollment Status: Terminated

Publish Date: October 09, 2025

Intervention Type: Drug

Study Drug: BIIB105

Study Phase: Phase 1/Phase 2

Open Label, Non-randomized Extension Trial to Assess Long Term Safety and Efficacy of Arimoclomol in Subjects With Amyotropic Lateral Sclerosis Who Have Completed the ORARIALS-01 Trial

Enrollment Status: Terminated

Publish Date: August 24, 2023

Intervention Type: Drug

Study Drug: Arimoclomol

Study Phase: Phase 3

A Phase 3, Randomised, Placebo-Controlled Trial of Arimoclomol in Amyotropic Lateral Sclerosis

Enrollment Status: Completed

Publish Date: August 24, 2023

Intervention Type: Drug

Study Phase: Phase 3

Safety and Efficacy of Tauroursodeoxycholic (TUDCA) as add-on Treatment in Patients Affected by Amyotrophic Lateral Sclerosis (ALS)

Enrollment Status: Unknown

Publish Date: July 10, 2023

Intervention Type: Drug

Study Drug: Tauroursodexycholic Acid

Study Phase: Phase 3

View 3 Less Clinical Trials

427 Total Publications

Genetic Variants Associated With Neurodegenerative Disorders in Patients With Amyotrophic Lateral Sclerosis and Phenotypic Variability.

Journal: Neurology

Published: September 25, 2025

View All 427 Publications

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Chio's expertise for a condition

ConditionClose